GSHR
NASDAQ · N/A
Gesher Acquisition Corp Ii-A
$10.59
+0.03 (+0.28%)
Open$10.58
Previous Close$10.56
Day High$10.59
Day Low$10.57
52W High$11.20
52W Low$9.51
Volume—
Avg Volume49.4K
Market Cap216.40M
P/E Ratio54.60
EPS$0.19
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 131.95M | 123.52M | 135.65M |
| Net Income | 15.49M | 14.46M | 19.18M |
| Profit Margin | 11.7% | 11.7% | 14.1% |
| EBITDA | 26.99M | 28.60M | 29.38M |
| Free Cash Flow | 13.81M | 14.94M | 16.93M |
| Rev Growth | -3.5% | +18.9% | -3.3% |
| Debt/Equity | 0.79 | 0.76 | 0.80 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.07 | -3.94% | — | 1.28B |
| PICS | Pics Nv | $8.97 | +6.41% | 4.6 | 1.18B |
| DMII | Drugs Made In America Acquis | $10.19 | +0.00% | 49.9 | 649.10M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.19% | 42.2 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.27 | +0.00% | 41.3 | 586.93M |